MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-11-0030074
Biojen Pharmaceuticals Private Limited
Biojen Pharmaceuticals Private Limited - trading in Delhi, India. Directors, charges & compliance details.
Revenue · FY 2025
₹19.49 Lakh
▼ 67% YoY
Net profit · FY 2025
₹40,880
Net margin 2.1%
EBITDA · FY 2025
₹49,014
EBITDA margin 2.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Biojen Pharmaceuticals Private Limited
Data last updated:
Biojen Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 23 February 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC394220.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Md Mushtaque Alam and Shabana Khatun.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Mohd Faizur Rab Faridy Plot 152 Th/F Vishwas Park T – Extn Uttam Nagar, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.49 Lakh, a decline of 67% compared to the previous year. For the same year it recorded a net profit of ₹40,880 (net margin 2.1%) and EBITDA of ₹49,014 (EBITDA margin 2.5%).
Biojen Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0030074). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909DL2022PTC394220
Registration Number 394220
Incorporation Date 23 February 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0030074
Recognitions & Rankings of Biojen Pharmaceuticals
Contact details
Biojen Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressC/O Mohd Faizur Rab Faridy Plot 152 Th/F Vishwas Park T – Extn Uttam Nagar, Delhi, India – 110059
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Biojen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Biojen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biojen Pharmaceuticals Private Limited, buy the company report.
Financials of Biojen Pharmaceuticals Private Limited
FY 2025 filings availableBiojen Pharmaceuticals Private Limited reported revenue of ₹19.49 Lakh (down 67% YoY) for FY 2025.
Revenue · FY 2025
₹19.49 Lakh ▼ 67%
Net profit · FY 2025
₹40,880 margin 2.1%
EBITDA · FY 2025
₹49,014 margin 2.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 67%
EBITDA CAGR growth
1 year
▼ 89%
Revenue fell 67% in the latest year. EBITDA fell 89% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹49,014 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹40,880 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.5% | |||
| Net Profit Margin | 2.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Biojen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biojen Pharmaceuticals Private Limited
Biojen Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Md Mushtaque Alam | Director | 23 Feb 2022 | 4 Years 8 Months | Current |
| Shabana Khatun | Additional Director | 01 Jan 2025 | 1 Years 10 Months | Current |
Peer comparison
Biojen Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rashrinivas Pharmaceuticals Private Limited | ₹19.54 Lakh (FY 2024) | 35.0% | Hyderabad, Telangana, India | |||
| Mercyking Pharmaceuticals Private Limited | ₹19.52 Lakh (FY 2024) | -22.0% | Panvel, Maharashtra, India | |||
| Biojen Pharmaceuticals Private Limitedthis company | ₹19.49 Lakh (FY 2025) | ₹40,880 | 2.1% | -67.0% | Delhi, India | |
| Ivy Nelson Pharmaceuticals Private Limited | ₹19.48 Lakh (FY 2019) | -14.0% | Piplod, Gujarat, India | |||
| Bromartis Pharmaceuticals Private Limited | ₹19.45 Lakh (FY 2017) | -78.0% | Jaipur, Rajasthan, India | |||
| Heartkind Pharmaceuticals Private Limited | ₹19.43 Lakh (FY 2021) | Jaipur, Rajasthan, India |
To see the full peer comparison of Biojen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biojen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biojen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biojen Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biojen Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Ashwini Kumar Gupta ceased to be Director on 01 Jan 2025.
AGM
Biojen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biojen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Ashwini Kumar Gupta ceased to be Director.
Appointed
Shabana Khatun was appointed as Additional Director.
Appointed
Md Mushtaque Alam was appointed as Director.
Incorporation
23 Feb 2022
Biojen Pharmaceuticals Private Limited was registered on 23 Feb 2022 with Roc Delhi Ii & aged 4 years 8 months as per MCA records.
Frequently asked questions
Biojen Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 23 February 2022 (4+ years old) and is registered under CIN U51909DL2022PTC394220.
Biojen Pharmaceuticals has 2 current directors:
- Md Mushtaque Alam - Director
- Shabana Khatun - Additional Director
The latest financial statements of Biojen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Biojen Pharmaceuticals is U51909DL2022PTC394220. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biojen Pharmaceuticals was incorporated on 23 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biojen Pharmaceuticals by revenue are Rashrinivas Pharmaceuticals Private Limited, Mercyking Pharmaceuticals Private Limited, Ivy Nelson Pharmaceuticals Private Limited, Bromartis Pharmaceuticals Private Limited, Heartkind Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashwini Kumar Gupta ceased to be Director on 01 Jan 2025. Shabana Khatun was appointed as Additional Director on 01 Jan 2025. Md Mushtaque Alam was appointed as Director on 23 Feb 2022.
Yes, Biojen Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0030074).
The registered office of Biojen Pharmaceuticals is at CO Mohd Faizur Rab Faridy Plot 152 ThF Vishwas Park T – Extn Uttam Nagar, Delhi, India – 110059.
Biojen Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Biojen Pharmaceuticals is compliant as of 13 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages